UBS Group’s John Hancock Multifactor Healthcare ETF JHMH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,365
| Closed | -$59K | – | 11930 |
|
|
2022
Q3 | $59K | Buy |
1,365
+1,065
| +355% | +$49.2K | ﹤0.01% | 6192 |
|
|
2022
Q2 | $14K | Sell |
300
-795
| -73% | -$37.3K | ﹤0.01% | 7470 |
|
|
2022
Q1 | $54K | Buy |
1,095
+982
| +869% | +$47.3K | ﹤0.01% | 6430 |
|
|
2021
Q4 | $6K | Sell |
113
-1,215
| -91% | -$60.2K | ﹤0.01% | 9349 |
|
|
2021
Q3 | $64K | Sell |
1,328
-253
| -16% | -$12.6K | ﹤0.01% | 6147 |
|
|
2021
Q2 | $76K | Sell |
1,581
-20,875
| -93% | -$971K | ﹤0.01% | 6091 |
|
|
2021
Q1 | $999K | Buy |
22,456
+339
| +2% | +$15K | ﹤0.01% | 4248 |
|
|
2020
Q4 | $956K | Sell |
22,117
-2,639
| -11% | -$111K | ﹤0.01% | 4065 |
|
|
2020
Q3 | $988K | Buy |
24,756
+1,488
| +6% | +$58.8K | ﹤0.01% | 3653 |
|
|
2020
Q2 | $875K | Sell |
23,268
-4,118
| -15% | -$152K | ﹤0.01% | 3621 |
|
|
2020
Q1 | $892K | Buy |
27,386
+2,381
| +10% | +$85.1K | ﹤0.01% | 3451 |
|
|
2019
Q4 | $931K | Buy |
25,005
+1,461
| +6% | +$51.4K | ﹤0.01% | 4289 |
|
|
2019
Q3 | $777K | Buy |
23,544
+2,761
| +13% | +$92.9K | ﹤0.01% | 4186 |
|
|
2019
Q2 | $710K | Buy |
20,783
+1,872
| +10% | +$62.7K | ﹤0.01% | 4021 |
|
|
2019
Q1 | $647K | Buy |
18,911
+18,261
| +2,809% | +$613K | ﹤0.01% | 3885 |
|
|
2018
Q4 | $21K | Buy |
+650
| New | +$21.9K | ﹤0.01% | 6768 |
|
|
2017
Q4 | – | Sell |
-2,240
| Closed | -$68K | – | 8201 |
|
|
2017
Q3 | $68K | Buy |
+2,240
| New | +$67.2K | ﹤0.01% | 5583 |
|
|
2016
Q3 | – | Sell |
-547
| Closed | -$14K | – | 8037 |
|
|
2016
Q2 | $14K | Buy |
+547
| New | +$14.2K | ﹤0.01% | 6580 |
|
|
2016
Q1 | – | Sell |
-26
| Closed | -$1K | – | 8365 |
|
|
2015
Q4 | $1K | Buy |
+26
| New | +$673 | ﹤0.01% | 8197 |
|
UBS Group's JHMH Position: Q4 2022 in Review
UBS Group sold out of John Hancock Multifactor Healthcare ETF (JHMH) in Q4 2022, closing a stake of 1,365 shares — an estimated $59K sold.
UBS Group first reported a position in JHMH in Q4 2015 and held it in 19 quarters. The position peaked at $999K in Q1 2021. 0 funds tracked by Wall St. Rank hold JHMH as of Q4 2022.
- UBS Group reported no remaining John Hancock Multifactor Healthcare ETF position as of Q4 2022 after selling out during the quarter.
- UBS Group sold 1,365 John Hancock Multifactor Healthcare ETF shares in Q4 2022, an estimated $59K.
- UBS Group first reported a position in John Hancock Multifactor Healthcare ETF in Q4 2015 and held it in 19 quarters.
- UBS Group's John Hancock Multifactor Healthcare ETF position peaked at $999K in Q1 2021.
- 0 funds tracked by Wall St. Rank held John Hancock Multifactor Healthcare ETF as of Q4 2022.
Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.